Prognostic factors associated with survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: An Australian multicenter cohort study

被引：0
|
作者：
Mishra, G. [1 ]
Dev, A. [1 ]
Paul, E. [3 ]
Roberts, S. [2 ]
机构：
[1] Monash Hlth, Gastroenterol Dept, Melbourne, Vic, Australia
[2] Alfred Hlth, Gastroenterol Dept, Melbourne, Vic, Australia
[3] Monash Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
476
引用
收藏
页码：93 / 94
页数：2
相关论文
共 50 条
  • [1] Prognostic factors associated with survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation: an Australian multicenter cohort study
    Mishra, Gauri
    Dev, Anouk
    Paul, Eldho
    Kemp, William
    Majeed, Ammar
    Lubel, John
    Bell, Sally
    Gow, Paul
    Nicoll, Amanda
    Sood, Siddharth
    Thompson, Alex
    Ryan, Marno
    Roberts, Stuart K.
    HEPATOMA RESEARCH, 2021, 7
  • [2] Inflammatory Markers as Prognostic Factors of Survival in Patients Affected by Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    Rebonato, A.
    Graziosi, L.
    Maiettini, D.
    Marino, E.
    De Angelis, V.
    Brunese, L.
    Mosca, S.
    Metro, G.
    Rossi, M.
    Orgera, G.
    Scialpi, M.
    Donini, A.
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2017, 2017
  • [3] Prognostic factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization and radioembolization: a retrospective study
    Jeliazkova, Petia
    Umgelter, Andreas
    Braren, Rickmer
    Kaissis, Georgios
    Mustafa, Mona
    Einwaechter, Henrik
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (08) : 1036 - 1041
  • [4] Prognostic factors of hepatocellular carcinoma patients treated by transarterial chemoembolization
    Xiao, Jun
    Li, Guojian
    Lin, Shuhan
    He, Ke
    Lai, Hao
    Mo, Xianwei
    Chen, Jiansi
    Lin, Yuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (03): : 1114 - 1123
  • [5] Incorporation of biochemical factors for survival analysis of transarterial chemoembolization in patients with hepatocellular carcinoma: A retrospective cohort study
    Chan, Wen-Hui
    Huang, Song-Fong
    Lee, Chao-Wei
    Wu, Tsung-Han
    Pan, Kuan-Tse
    Lin, Shi-Ming
    Yu, Ming-Chin
    Hung, Chien-Fu
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (10) : 4862 - 4871
  • [6] Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization
    Yossi Ventura
    Brian I Carr
    Issac Kori
    Vito Guerra
    Oren Shibolet
    World Journal of Gastroenterology, 2018, (15) : 1641 - 1649
  • [7] Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization
    Ventura, Yossi
    Carr, Brian I.
    Kori, Issac
    Guerra, Vito
    Shibolet, Oren
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (15) : 1641 - 1649
  • [8] Real adjuvant transarterial chemoembolization is not associated with good survival in most patients with hepatocellular carcinoma: A multicenter retrospective study
    Li, J-R.
    Su, J-Y.
    Huang, D-J.
    Liu, S.
    Xu, X-L.
    Ou, J-J.
    Chen, S-C.
    Ma, Y-L.
    Ma, L.
    Zhong, J-H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1489 - S1490
  • [9] Prevalence and prognostic impact of hepatopulmonary syndrome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective cohort study
    Zhao He
    Tsauo Jiaywei
    Zhang Xiaowu
    Ma Huaiyuan
    Weng Ningna
    Yang Zhengqiang
    Li Xiao
    中华医学杂志英文版, 2022, 135 (17)
  • [10] Prevalence and prognostic impact of hepatopulmonary syndrome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective cohort study
    Zhao, He
    Tsauo, Jiaywei
    Zhang, Xiaowu
    Ma, Huaiyuan
    Weng, Ningna
    Yang, Zhengqiang
    Li, Xiao
    CHINESE MEDICAL JOURNAL, 2022, 135 (17) : 2043 - 2048
12345